ATS 2025: The Global Stage for AI-Powered Chest CT Innovation
The ATS 2025 International Conference, hosted by the American Thoracic Society, will take place in San Francisco, CA from May 16 to 21, 2025. As the world’s leading academic event for pulmonary, critical care, and sleep medicine, this year’s program will highlight the fast-growing role of AI in thoracic imaging and clinical decision support.
Event Detail
|
Information |
Event Name |
ATS 2025 International Conference |
Date |
May 16 (Fri) – May 21 (Wed), 2025 |
Venue |
San Francisco, California, USA |
Organizer |
American Thoracic Society (ATS) |
Key Topics |
AI in chest CT analysis, lung cancer screening, pulmonary diagnostics, clinical workflow automation |
Why ATS 2025 Matters for Chest CT AI
The demand for low-dose chest CT (LDCT) in lung cancer screening is rising. Radiologists are facing growing pressure with increased scan volume and nodule detection rates. AI-powered CT interpretation tools are evolving to support faster, more consistent, and more scalable workflows.
ATS 2025 will be a key opportunity to explore how medical AI is addressing clinical pain points—from lung nodule assessment to longitudinal tracking and malignancy risk prediction.
Coreline Soft at ATS 2025
Coreline Soft will participate in ATS 2025 to showcase AVIEW LCS Plus, a globally certified AI platform for 3-in-1 chest CT analysis. From a single scan, the system simultaneously detects and analyzes:
- Lung nodules (lung cancer screening)
- Coronary artery calcification (cardiovascular risk)
- Emphysema and air trapping (COPD assessment)
Backed by FDA, CE, HIPAA, and GDPR compliance, Coreline’s solution is currently implemented in multi-country lung screening programs across Europe and Asia.